Cargando…
Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia
Hyperinsulinaemic hypoglycaemia (HH) is a biochemical finding of low blood glucose levels due to the dysregulation of insulin secretion from pancreatic β-cells. Under normal physiological conditions, glucose metabolism is coupled to β-cell insulin secretion so that blood glucose levels are maintaine...
Autores principales: | Haris, Basma, Saraswathi, Saras, Hussain, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720331/ https://www.ncbi.nlm.nih.gov/pubmed/33329885 http://dx.doi.org/10.1177/2042018820965068 |
Ejemplares similares
-
The Diagnosis and Management of Hyperinsulinaemic Hypoglycaemia
por: Roženková, Klára, et al.
Publicado: (2015) -
Hyperinsulinaemic Hypoglycaemia: Genetic Mechanisms, Diagnosis and Management
por: Mohamed, Zainaba, et al.
Publicado: (2012) -
Diagnosis and treatment of hyperinsulinaemic hypoglycaemia and its implications for paediatric endocrinology
por: Demirbilek, Huseyin, et al.
Publicado: (2017) -
Genotype and phenotype correlations in Iranian patients with hyperinsulinaemic hypoglycaemia
por: Senniappan, Senthil, et al.
Publicado: (2015) -
An Evaluation of Growth Hormone and IGF-1 Responses in Neonates with Hyperinsulinaemic Hypoglycaemia
por: Senniappan, Senthil, et al.
Publicado: (2013)